Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.
Publication
, Journal Article
Othus, M; Estey, EH; Garcia-Manero, G; Wood, BL; Stirewalt, DL; Godwin, JE; Weick, JK; Anderson, JE; Appelbaum, FR; Erba, HP; Walter, RB
Published in: Leukemia
February 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
February 2019
Volume
33
Issue
2
Start / End Page
554 / 558
Location
England
Related Subject Headings
- Young Adult
- Treatment Outcome
- Survival Rate
- Remission Induction
- Middle Aged
- Male
- Leukemia, Myeloid, Acute
- Immunology
- Humans
- Gemtuzumab
Citation
APA
Chicago
ICMJE
MLA
NLM
Othus, M., Estey, E. H., Garcia-Manero, G., Wood, B. L., Stirewalt, D. L., Godwin, J. E., … Walter, R. B. (2019). Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia, 33(2), 554–558. https://doi.org/10.1038/s41375-018-0274-y
Othus, Megan, Elihu H. Estey, Guillermo Garcia-Manero, Brent L. Wood, Derek L. Stirewalt, John E. Godwin, James K. Weick, et al. “Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.” Leukemia 33, no. 2 (February 2019): 554–58. https://doi.org/10.1038/s41375-018-0274-y.
Othus M, Estey EH, Garcia-Manero G, Wood BL, Stirewalt DL, Godwin JE, et al. Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia. 2019 Feb;33(2):554–8.
Othus, Megan, et al. “Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.” Leukemia, vol. 33, no. 2, Feb. 2019, pp. 554–58. Pubmed, doi:10.1038/s41375-018-0274-y.
Othus M, Estey EH, Garcia-Manero G, Wood BL, Stirewalt DL, Godwin JE, Weick JK, Anderson JE, Appelbaum FR, Erba HP, Walter RB. Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia. 2019 Feb;33(2):554–558.
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
February 2019
Volume
33
Issue
2
Start / End Page
554 / 558
Location
England
Related Subject Headings
- Young Adult
- Treatment Outcome
- Survival Rate
- Remission Induction
- Middle Aged
- Male
- Leukemia, Myeloid, Acute
- Immunology
- Humans
- Gemtuzumab